Der Ultimative Calyptemotivationsthread

aus US Board:


By: blossom_rock
10 Jun 2004, 08:41 PM EDT Msg. 51660 of 51664


Let's see now. We have a test that says
"How long have you had HIV"???
Link-
news.moneycentral.msn.com/ticker/...R&Date=20040414&ID=3583729
(remember the CDC is also involved in this conspiracy)

Then we finalize Thailand manufacturing......

Link-
news.moneycentral.msn.com/ticker/...R&Date=20040511&ID=3687042

Then we start China manufacturing deal....

Link-
news.moneycentral.msn.com/ticker/...R&Date=20040513&ID=3697401

Now we move onto "real CLINICAL STUDIES"

In addition, the Calypte rapid oral fluid assay has been in an independent clinical study at the Anonymous Clinic in Bangkok, Thailand for more than a month and results are encouraging.

Dr. Richard George, President and CEO of Calypte stated that "HIV Vanguard (TM) OMT" provides the final piece to the Calypte menu of tests that offers the HIV testing community the opportunity to choose from a complete line of rapid tests that can be used to test urine, oral fluid, whole blood, and serum/plasma. Our blood rapid test is fully validated and transfer of this technology to our manufacturing partner is underway. Urine and oral fluid are in the final phases of field testing and if testing continues at the current level of performance, we expect that these tests will be ready for market in the second half of 2004."

And the above mentions 2004 sales by the way........

Link-
news.moneycentral.msn.com/ticker/...R&Date=20040525&ID=3737563

Calypte Biomedical Raises $9.3 Million in Private Placement
Linko-
news.moneycentral.msn.com/ticker/...R&Date=20040601&ID=3756313

Grandmama


Viel Glück
Smoky

Calypte Files Registration Statement  
WEDNESDAY, JUNE 16, 2004 9:59 AM
- PR Newswire




 CYPT
 0.52  +0.02  


   


   Enter Symbol:
 


   Enter Keyword:
 


ALAMEDA, Calif., Jun 16, 2004 /PRNewswire-FirstCall via COMTEX/ -- Calypte Biomedical Corporation (CYPT) , a developer, manufacturer and marketer of HIV diagnostic tests, today announced that it has filed a registration statement (the "Registration Statement") with the Securities and Exchange Commission registering shares of common stock purchased and shares of common stock underlying warrants purchased in its recent private placement (the "May 2004 PIPE"), as well as other unregistered shares of common stock, primarily owned by Marr Technologies BV, an affiliate of Calypte and its largest stockholder.

Calypte currently has approximately 164 million shares of common stock issued and outstanding, which includes approximately 71 million of the shares being registered pursuant to the Registration Statement. These shares being registered represent approximately 43% of the Company's currently issued and outstanding common stock. Of the 71 million shares, approximately 51 million are owned by affiliates of Calypte, and the balance by investors in the May 2004 PIPE other than affiliates of Calypte and other financings, as well as vendors and consultants who have received common stock in lieu of cash.

The Registration Statement provides for the issuance of an additional 12 million shares, which includes approximately 9 million shares to be held for issuance upon exercise of the warrants issued in the May 2004 PIPE. Affiliates of Calypte hold about 70% of those warrants.